Covid-19 Resource Center
During these turbulent times, finding information is hard. The Quadax Resource Center will help keep you up to date on the latest COVID-19 topics, including laboratory testing, supply needs and payor and billing changes affecting reimbursement.
COVID-19 Payer Updates
Quadax is dedicated to keeping our clients up-to-date on the billing, reporting, and procedural information specific to each payer as it pertains to COVID-19.
Recent Blog Posts
The COVID-19 Evolution—Variants and Vaccines
Viruses are constantly changing, and this includes SARS-CoV-2, the virus that causes COVID-19. These genetic variations occur over time and can lead to the emergence of new variants that may have different characteristics. Although none of the experts know exactly how COVID-19 will evolve or how the vaccines will affect the spread, it seems like there is a general consensus among the medical community that COVID-19 will be around for some time.
COVID-19 Articles, Bulletins, Town Halls, Webinars
Date | Article | Source |
7/21/2021 | Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing | |
7/20/2021 | Lab Advisory: SARS-CoV-2 Variant Classification Updates | |
7/18/2021 | Lab Alert: FDA Revokes EUA for Curative SARS-CoV-2 Assay | |
7/15/2021 | Lab Advisory: CDC Updates Pooling Guidance and Overview of Testing for SARS-CoV-2 Web Pages | |
7/13/2021 | Revised fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination. | |
7/8/2021 | COVID-19 Snapshot: Impact on the Medicare Population | |
7/8/2021 | COVID-19 Accelerated and Advance Payments: Updated FAQs. | |
7/6/2021 | Lab Advisory: SARS-CoV-2 Variants AY.1 and AY.2 Now Aggregated with Delta Variant B.1.617.2 | |
6/30/2021 | CDC Launches New COVID-19 Viral Testing Tool | |
6/29/2021 | Lab Update: SARS-CoV-2 Variant Classification Changes | |
6/17/2021 | CMS Infographic: Medicare Payment for COVID-19 Vaccination Administered in the Home | |
6/16/2021 | CDC Updates Guidance for Reporting SARS-CoV-2 Sequencing Results. | |
6/15/2021 | Coronavirus (COVID-19) Update | |
6/14/2021 | Lab Alert: Sodium Citrate Blood Specimen Collection Tubes in Short Supply | |
6/14/2021 | Lab Advisory: CDC Launches New COVID-19 Viral Testing Tool | |
6/10/2021 | CMS increase provider payment for in-home COVID-19 vaccinations | |
6/9/2021 | Biden Administration Continues Efforts to Increase Vaccinations by Bolstering Payments for At-Home COVID-19 Vaccinations for Medicare Beneficiaries | |
6/9/2021 | HHS Secretary Xavier Becerra to Insurers & Providers: COVID-19 Vaccines and Testing Must be Free for Patients | |
5/28/2021 | Lab Advisory: CDC Updates Testing Strategies for SARS-CoV-2 Web Page | |
5/25/2021 | Coronavirus (COVID-19) Update: May 25, 2021 | |
5/25/2021 | HHS to Dedicate $4.8 Billion from American Rescue Plan to COVID-19 Testing for the Uninsured | |
5/21/2021 | Coronavirus (COVID-19) Update: May 21, 2021 | |
5/20/2021 | Lab Advisory: CDC Updates NAATs and Self-Testing Web Pages | |
5/19/2021 | Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication | |
5/18/2021 | CDC Updates Interim Guidance for Antigen Testing for SARS-CoV-2 | |
5/5/2021 | SARS-CoV-2 Variant Classifications and Definitions | |
5/3/2021 | HHS Launches New Reimbursement Program for COVID-19 Vaccine Administration Fees not Covered by Insurance | |
4/26/2021 | Time to Say Goodbye to Some Insurers’ Waivers for Covid Treatment Fees | |
4/21/2021 | FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines | |
4/20/2021 | The FDA issued a pooling and serial testing amendment for many molecular diagnostic COVID-19 tests that had received an emergency use authorization (EUA) for testing individual samples. | |
4/16/2021 | Medicare FFS Claims: | |
4/15/2021 | Message from HHS-OIG Leadership on the COVID-19 Vaccination Program and Provider Compliance | |
4/6/2021 | The FDA issued an Emergency Use Authorization (EUA) to Symbiotica, Inc., for the COVID-19 Self-Collected Antibody Test System | |
4/2/2021 | HHS Secretary Xavier Becerra Announces Expansion of COVID-19 Vaccine Program to All Community Health Centers Across the Country | |
4/2/2021 | New web page posted: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular, antigen, and serology tests | |
4/1/2021 | Repayment of COVID-19 Accelerated and Advance Payments Began on March 30, 2021 | |
3/30/2021 | Updated Serology EUA COVID-19 Templates Available | |
3/30/2021 | New FDA web page - SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests - for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular tests | |
3/26/2021 | FDA issues emergency use authorization (EUA) to the Twist Bioscience Corporation for their SARS-CoV-2 NGS Assay | |
3/26/2021 | Lab Advisory: CDC Publishes New Web Page on Nucleic Acid Amplification Tests (NAATs) | |
3/22/2021 | Lab Update: CMS Posts FAQ for Reporting Sequencing Results for SARS-CoV-2 Variants | |
3/15/2021 | Medicare Payment Increase for COVID-19 Vaccine | |
3/13/2021 | Lab Alert: FDA Issues Letter about Potential False Results with Roche cobas SARS-CoV-2 & Influenza Test | |
3/9/2021 | Senate Passes $1.9 Trillion COVID-19 Bill; Several CAP-Backed Provisions Move Forward | |
3/9/2021 | FDA issued an Emergency Use Authorization (EUA) to Cue Health Inc. for its over-the-counter at-home diagnostic test for COVID-19. | |
3/9/2021 | Medicare Part B Payment for COVID-19 Vaccines and Certain Monoclonal Antibodies during the Public Health Emergency | |
3/5/2021 | COVID-19 Update: FDA Issues Authorization for First Molecular Non-Prescription, At-Home Test | |
3/4/2021 | COVID-19 Vaccine Administration: Insurance Coverage, MBI, & MSP | |
3/2/2021 | Lab Advisory: FDA Issues New Guidance for Evaluating Impact of Viral Mutations on COVID-19 Tests | |
3/2/2021 | COVID-19 Update: The agency issued an Emergency Use Authorization (EUA) to Quidel for its QuickVue At-Home COVID-19 Test for at-home use with a prescription | |
2/27/2021 | House Approves Large COVID-19 Relief Bill; Includes $7.5 Billion for Vaccine Distribution | |
2/26/2021 | Biden Administration Strengthens Requirements that Plans and Issuers Cover COVID-19 Diagnostic Testing Without Cost Sharing and Ensures Providers are Reimbursed for Administering COVID-19 Vaccines to Uninsured | |
2/26/2021 | ACLA Statement on President Biden’s Actions to Close Coverage Gaps for COVID-19 Testing | |
2/12/2021 | COVID-19 Update: The FDA revised its guidance, Investigational COVID-19 Convalescent Plasma and associated web page, to reflect the reissued Emergency Use Authorization for COVID-19 convalescent plasma | |
2/11/2021 | COVID-19: Revised Clinician Codes Accepted with CS Modifier | |
2/3/2021 | COVID-19 Claims Reimbursement Program Update for the Uninsured | |
2/2/2021 | Lab Advisory: CDC Publishes New Web Pages on Genomic Surveillance for SARS-CoV-2 Variants | |
1/29/2021 | COVID-19 Update: The FDA has added content to the Q&A appendix in “Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency" | |
1/28/2021 | HHS Announces Marketplace Special Enrollment Period for COVID-19 Public Health Emergency | |
1/21/2021 | ACLA Statement on President Biden's Actions to Combat COVID-19 | |
1/19/2021 | Find your COVID-19 Vaccine CPT® Codes | |
1/8/2021 | FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff | |
1/8/2021 | Coronavirus (COVID-19) Update: January 8, 2021 | |
1/4/2021 | New ICD-10-CM code for the | |
12/22/2020 | Coronavirus (COVID-19) Update: December 22, 2020 | |
12/19/2020 | CMS Updates FAQs for CLIA Guidance during the COVID-19 Public Health Emergency | |
12/15/2020 | FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine | |
12/15/2020 | FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19 | |
12/11/2020 | COVID-19 and in vitro diagnostics: New market forces at play | |
12/10/2020 | CMS offers guidance in billing Medicare for COVID-19 antibody treatment | |
12/10/2020 | FAQs–Application of OIG's Administrative Enforcement Authorities to Arrangements Directly Connected to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency | |
12/7/2020 | Lab Advisory: CMS Revises Enforcement Discretion for SARS-CoV-2 Point-of-Care Tests | |
12/5/2020 | Lab Update: CDC Updates SARS-CoV-2 Antigen Testing Guidance | |
12/3/2020 | Lab Update: CDC Offers New COVID-19 Specimen Collection Infographics | |
12/4/2020 | 13 insurers extending COVID-19 cost-sharing waivers into 2021 | |
12/3/2020 | COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) Billing | |
12/1/2020 | Job Aids for Laboratory Professionals | |
12/1/2020 | Clinical Laboratory COVID-19 Response Calls | |
11/24/2020 | Guidance for SARS-CoV-2 Point-of-Care Testing | |
11/24/2020 | Pathologists Advocate for Higher COVID-19 Payments During AMA Meeting | |
11/24/2020 | A Closer Look at COVID-19 Diagnostic Testing | |
11/23/2020 | 2020 Clinical Lab & Pathology Resources | |
11/19/2020 | HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19 | |
11/18/2020 | Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation | |
11/18/2020 | The FDA issued an EUA for the first COVID-19 diagnostic test for self-testing at home that provides rapid results | |
11/18/2020 | The FDA published a new "FDA Insight" podcast titled: "Personal Protective Equipment and COVID-19" | |
11/17/2020 | CAP Members Call on Congress to Stop Medicare Cuts | |
11/17/2020 | CAP Asks CMS to Reduce COVID-19 Laboratory Reporting Burdens, Increase Testing Resources | |
11/11/2020 | CMS Details Medicare Payment for New COVID-19 Antibody Drug | |
11/10/2020 | AMA Announces Vaccine-Specific CPT Codes for COVID-19 Immunizations | |
11/9/2020 | The FDA issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients | |
11/2/2020 | Clinical Laboratories Need Creative Staffing Strategies to Keep and Attract Hard-to-Find Medical Technologists, as Demand for COVID-19 Testing Increases |
